French radiology artificial intelligence (AI) software developer Gleamer has received 7.5 million euros from a series A financing round.
The funds will be used to boost the market launch of its BoneView AI software for detecting traumatic injuries on radiographs, as well as to obtain U.S. Food and Drug Administration (FDA) clearance, according to Gleamer. The vendor said it would also use the investment to continue developing its AI technology in other areas of radiology.
The investment round was led by XAnge, alongside new investors MACSF, Majycc eSanté Invest, and Crista Galli Ventures. Previous investors Elaia and the state-run fund Ambition Amorçage Angels (F3A) also participated, along with 37 radiologists, Gleamer said.
